Skip to main content

OMND · Optimind Pharma Corp. · Financials

0.0050 CAD -0.0050 (-50.00%) At close · Aug 19 Intraday price with Plus
Market Cap
515,742 CAD
Shares
103.15M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
121.29K +2.5%
FY2026 Revenue FY2025–FY2026
Net Income
-117.94K +45.4%
FY2026 Net Income FY2025–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 FY2025
CAD 121.29K 118.37K
CAD -117.94K -215.81K
CAD -117.94K -215.81K
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.